Syneron Medical (NSDQ:ELOS) dropped a patent infringement lawsuit against EndyMed Medical and its distributor, Eclipse Aesthetics, after EndyMed agreed to stop selling its fractional skin resurfacing products in the U.S.

EndyMed will continue to re-supply electrodes and other maintenance items for the products it has already sold, according to a press release.

Sign up to get our free newsletters delivered right to your inbox

The Israel-based aesthetic medical device maker sued EndyMed in October 2012, claiming that EndyMed infringes on 2 patents for an energy-based skin tightening technology. Syneron’s devices apply ablative energy to the skin, and the company took issue with EndyMed’s Pro and Glow skin tightening systems and related devices.

EndyMed and Eclipse agreed to stop selling the devices, ending Syneron’s quest for permanent injunction over the patents, according to the release. Syneron Medical manufactures medical aesthetic devices, primarily for hair removal and skin tightening.